Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7419975 Organic compounds

Patent 7419975 was granted and assigned to Novartis on September, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74199750

Patent Inventor Names

Yanlin Zhang0

Yaping Wang0

Zhuoliang Chen0

Leigh Scott Zawel0

Christopher Straub0

Fan Yang0

Feng He0

Gang Liu0

...

Date of Patent

September 2, 2008

Patent Application Number

110999410

Date Filed

April 6, 2005

Patent Citations Received

‌

US Patent 11857519 Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

‌

US Patent 11986531 Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides

‌

US Patent 11957759 Rapidly accelerated fibrosarcoma (RAF) degrading compounds and associated methods of use

‌

US Patent 11707452 Modulators of alpha-synuclein proteolysis and associated methods of use

‌

US Patent 11912699 Tau-protein targeting compounds and associated

Patent Primary Examiner

‌

Rebecca L Anderson

Patent abstract

Novel compounds that inhibit the binding of the Smac protein to Inhibitor of Apoptosis Proteins (IAPs) of the formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7419975 Organic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API